Please assess the completion status of the following clinical trial:

Trial Title: Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \>18 year old male and female patients~2. All patients are referred for elective cardiac catheterization based on clinical indication~3. Cath shows mild or moderate (\<70% stenosis) CAD that does not require mechanical intervention~Exclusion Criteria:~1. Severe stenosis requires intervention.~2. Significant left main coronary artery disease (\>40%).~3. Acute MI or acute coronary syndrome with enzyme elevation or ischemic EKG changes~4. Patients with severe left ventricular dysfunction (EF\<35%)~5. Prior history of myocardial infarction~6. History of stroke within 3 months.~7. Recent history of thrombolytic~8. History of coronary intervention within previous 6 months.~9. Patients with history of coronary spasm~10. Patients with congestive heart failure (class III and IV).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Bradykinin

Based on this trial design, predict the completion outcome and termination type (if applicable).